{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-021075","form_type":"8-K","ticker":"AGL","cik":"0001831097","company_name":"agilon health, inc.","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.506626+00:00","generated_at":"2026-06-02T19:54:21.721746+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"agilon health Q1 revenue up 52% to $1.6B, net loss $6M; lowers FY2024 member & revenue guidance","bullets":["Revenue $1.60B (+52% YoY); net loss of $6M vs net income $16M in Q1 2023.","Medical margin $157M (flat YoY); adjusted EBITDA $29M (+21%).","MA membership 523k (+43%), total platform members 654k.","Full-year guidance: MA members lowered to 510-515k; revenue lowered to $6.125-6.175B; medical margin & adj. EBITDA unchanged.","Announced 5 new physician partnerships for Class of 2025, adding 60k+ MA members."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-021075","json":"https://secwatch.observer/filing/0001628280-24-021075.json","markdown":"https://secwatch.observer/filing/0001628280-24-021075.md","text":"https://secwatch.observer/filing/0001628280-24-021075.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831097/000162828024021075/0001628280-24-021075-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831097/000162828024021075/agl-20240507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T19:54:21.721746+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d667505ad0dd2bcc50572fc92f60e0f67938a9cc","claim":"agilon health, inc. updated its the first quarter ended March 31, 2024 guidance (reaffirmed).","evidence_excerpt":"On May 7, 2024 , agilon health, inc. (the “Company”), a Delaware corporation, issued a press release setting forth its financial results for the three months ended March 31, 2024.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831097/000162828024021075/0001628280-24-021075-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2024"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}